We've found
15,419
archived clinical trials in
Pulmonary
We've found
15,419
archived clinical trials in
Pulmonary
A Pilot Study of Pulmonary Function in Dysphagic Infants
A Pilot Study of Pulmonary Function in Dysphagic Infants
Status: Archived
A Pilot Study of Pulmonary Function in Dysphagic Infants
Updated: 1/1/1970
A Pilot Study of Pulmonary Function in Dysphagic Infants
Status: Archived
Updated: 1/1/1970
In Vitro Basophil Responsiveness to Allergen Challenge After Gamma-tocopherol Supplementation in Allergic Asthmatics
In Vitro Basophil Responsiveness to Allergen Challenge After Gamma-tocopherol Supplementation in Allergic Asthmatics
Status: Archived
In Vitro Basophil Responsiveness to Allergen Challenge After Gamma-tocopherol Supplementation in Allergic Asthmatics
Updated: 1/1/1970
In Vitro Basophil Responsiveness to Allergen Challenge After Gamma-tocopherol Supplementation in Allergic Asthmatics
Status: Archived
Updated: 1/1/1970
Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant Recipients
Anidulafungin Versus Fluconazole for the Prevention of Invasive Fungal Infections in High-risk Liver Transplant Recipients: a Randomized, Double-blind Trial
Status: Archived
Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant Recipients
Updated: 1/1/1970
Anidulafungin Versus Fluconazole for the Prevention of Invasive Fungal Infections in High-risk Liver Transplant Recipients: a Randomized, Double-blind Trial
Status: Archived
Updated: 1/1/1970
Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant Recipients
Anidulafungin Versus Fluconazole for the Prevention of Invasive Fungal Infections in High-risk Liver Transplant Recipients: a Randomized, Double-blind Trial
Status: Archived
Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant Recipients
Updated: 1/1/1970
Anidulafungin Versus Fluconazole for the Prevention of Invasive Fungal Infections in High-risk Liver Transplant Recipients: a Randomized, Double-blind Trial
Status: Archived
Updated: 1/1/1970
Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant Recipients
Anidulafungin Versus Fluconazole for the Prevention of Invasive Fungal Infections in High-risk Liver Transplant Recipients: a Randomized, Double-blind Trial
Status: Archived
Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant Recipients
Updated: 1/1/1970
Anidulafungin Versus Fluconazole for the Prevention of Invasive Fungal Infections in High-risk Liver Transplant Recipients: a Randomized, Double-blind Trial
Status: Archived
Updated: 1/1/1970
Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant Recipients
Anidulafungin Versus Fluconazole for the Prevention of Invasive Fungal Infections in High-risk Liver Transplant Recipients: a Randomized, Double-blind Trial
Status: Archived
Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant Recipients
Updated: 1/1/1970
Anidulafungin Versus Fluconazole for the Prevention of Invasive Fungal Infections in High-risk Liver Transplant Recipients: a Randomized, Double-blind Trial
Status: Archived
Updated: 1/1/1970
Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant Recipients
Anidulafungin Versus Fluconazole for the Prevention of Invasive Fungal Infections in High-risk Liver Transplant Recipients: a Randomized, Double-blind Trial
Status: Archived
Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant Recipients
Updated: 1/1/1970
Anidulafungin Versus Fluconazole for the Prevention of Invasive Fungal Infections in High-risk Liver Transplant Recipients: a Randomized, Double-blind Trial
Status: Archived
Updated: 1/1/1970
Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant Recipients
Anidulafungin Versus Fluconazole for the Prevention of Invasive Fungal Infections in High-risk Liver Transplant Recipients: a Randomized, Double-blind Trial
Status: Archived
Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant Recipients
Updated: 1/1/1970
Anidulafungin Versus Fluconazole for the Prevention of Invasive Fungal Infections in High-risk Liver Transplant Recipients: a Randomized, Double-blind Trial
Status: Archived
Updated: 1/1/1970
Immunological Characterization of Bronchoalveolar Cells in Normals
Immunological Characterization of Bronchoalveolar Cells in Normals
Status: Archived
Immunological Characterization of Bronchoalveolar Cells in Normals
Updated: 1/1/1970
Immunological Characterization of Bronchoalveolar Cells in Normals
Status: Archived
Updated: 1/1/1970
Electrocardiographic Autonomic Function Measures in Mechanically Ventilated Patients
The Value of Electrocardiographic Autonomic Nervous System Function Measures for Predicting Cardiopulmonary Recovery of Mechanically Ventilated Patients in Intensive Care
Status: Archived
Electrocardiographic Autonomic Function Measures in Mechanically Ventilated Patients
Updated: 1/1/1970
The Value of Electrocardiographic Autonomic Nervous System Function Measures for Predicting Cardiopulmonary Recovery of Mechanically Ventilated Patients in Intensive Care
Status: Archived
Updated: 1/1/1970
Asthma Exacerbation and Helium-3 MRI
Updated: 1/1/1970
Asthma Exacerbation and Helium-3 MRI
Status: Archived
Updated: 1/1/1970
Assessment of Arformoterol for Chronic Obstructive Pulmonary Disease (COPD) Using Hyperpolarized 3He MRI
Assessment of Arformoterol for COPD Using Hyperpolarized 3He MRI
Status: Archived
Assessment of Arformoterol for Chronic Obstructive Pulmonary Disease (COPD) Using Hyperpolarized 3He MRI
Updated: 1/1/1970
Assessment of Arformoterol for COPD Using Hyperpolarized 3He MRI
Status: Archived
Updated: 1/1/1970
Hyperpolarized Noble Gas MR Imaging for Pulmonary Disorders
Hyperpolarized Noble Gas MR Imaging for Pulmonary Disorders
Status: Archived
Hyperpolarized Noble Gas MR Imaging for Pulmonary Disorders
Updated: 1/1/1970
Hyperpolarized Noble Gas MR Imaging for Pulmonary Disorders
Status: Archived
Updated: 1/1/1970
Exploratory Study of Xolair in Chronic Obstructive Pulmonary Disease in Patients With Elevated IgE Levels
Exploratory Study of Xolair (Omalizumab)to Improve Outcomes in Patients With COPD and Elevated IgE Levels, and Positive RAST or Skin Prick Tests
Status: Archived
Exploratory Study of Xolair in Chronic Obstructive Pulmonary Disease in Patients With Elevated IgE Levels
Updated: 1/1/1970
Exploratory Study of Xolair (Omalizumab)to Improve Outcomes in Patients With COPD and Elevated IgE Levels, and Positive RAST or Skin Prick Tests
Status: Archived
Updated: 1/1/1970
An Observational Study of Fungal Biomarkers (0000-089)
A Prospective, Non-Intervention, Observational Assessment of the Correlation Between Circulating Biomarkers of Fungal Bioburden and Clinical Outcome in the Setting of Invasive Aspergillosis
Status: Archived
An Observational Study of Fungal Biomarkers (0000-089)
Updated: 1/1/1970
A Prospective, Non-Intervention, Observational Assessment of the Correlation Between Circulating Biomarkers of Fungal Bioburden and Clinical Outcome in the Setting of Invasive Aspergillosis
Status: Archived
Updated: 1/1/1970
An Observational Study of Fungal Biomarkers (0000-089)
A Prospective, Non-Intervention, Observational Assessment of the Correlation Between Circulating Biomarkers of Fungal Bioburden and Clinical Outcome in the Setting of Invasive Aspergillosis
Status: Archived
An Observational Study of Fungal Biomarkers (0000-089)
Updated: 1/1/1970
A Prospective, Non-Intervention, Observational Assessment of the Correlation Between Circulating Biomarkers of Fungal Bioburden and Clinical Outcome in the Setting of Invasive Aspergillosis
Status: Archived
Updated: 1/1/1970
An Observational Study of Fungal Biomarkers (0000-089)
A Prospective, Non-Intervention, Observational Assessment of the Correlation Between Circulating Biomarkers of Fungal Bioburden and Clinical Outcome in the Setting of Invasive Aspergillosis
Status: Archived
An Observational Study of Fungal Biomarkers (0000-089)
Updated: 1/1/1970
A Prospective, Non-Intervention, Observational Assessment of the Correlation Between Circulating Biomarkers of Fungal Bioburden and Clinical Outcome in the Setting of Invasive Aspergillosis
Status: Archived
Updated: 1/1/1970
An Observational Study of Fungal Biomarkers (0000-089)
A Prospective, Non-Intervention, Observational Assessment of the Correlation Between Circulating Biomarkers of Fungal Bioburden and Clinical Outcome in the Setting of Invasive Aspergillosis
Status: Archived
An Observational Study of Fungal Biomarkers (0000-089)
Updated: 1/1/1970
A Prospective, Non-Intervention, Observational Assessment of the Correlation Between Circulating Biomarkers of Fungal Bioburden and Clinical Outcome in the Setting of Invasive Aspergillosis
Status: Archived
Updated: 1/1/1970
An Observational Study of Fungal Biomarkers (0000-089)
A Prospective, Non-Intervention, Observational Assessment of the Correlation Between Circulating Biomarkers of Fungal Bioburden and Clinical Outcome in the Setting of Invasive Aspergillosis
Status: Archived
An Observational Study of Fungal Biomarkers (0000-089)
Updated: 1/1/1970
A Prospective, Non-Intervention, Observational Assessment of the Correlation Between Circulating Biomarkers of Fungal Bioburden and Clinical Outcome in the Setting of Invasive Aspergillosis
Status: Archived
Updated: 1/1/1970
An Observational Study of Fungal Biomarkers (0000-089)
A Prospective, Non-Intervention, Observational Assessment of the Correlation Between Circulating Biomarkers of Fungal Bioburden and Clinical Outcome in the Setting of Invasive Aspergillosis
Status: Archived
An Observational Study of Fungal Biomarkers (0000-089)
Updated: 1/1/1970
A Prospective, Non-Intervention, Observational Assessment of the Correlation Between Circulating Biomarkers of Fungal Bioburden and Clinical Outcome in the Setting of Invasive Aspergillosis
Status: Archived
Updated: 1/1/1970
An Observational Study of Fungal Biomarkers (0000-089)
A Prospective, Non-Intervention, Observational Assessment of the Correlation Between Circulating Biomarkers of Fungal Bioburden and Clinical Outcome in the Setting of Invasive Aspergillosis
Status: Archived
An Observational Study of Fungal Biomarkers (0000-089)
Updated: 1/1/1970
A Prospective, Non-Intervention, Observational Assessment of the Correlation Between Circulating Biomarkers of Fungal Bioburden and Clinical Outcome in the Setting of Invasive Aspergillosis
Status: Archived
Updated: 1/1/1970
An Observational Study of Fungal Biomarkers (0000-089)
A Prospective, Non-Intervention, Observational Assessment of the Correlation Between Circulating Biomarkers of Fungal Bioburden and Clinical Outcome in the Setting of Invasive Aspergillosis
Status: Archived
An Observational Study of Fungal Biomarkers (0000-089)
Updated: 1/1/1970
A Prospective, Non-Intervention, Observational Assessment of the Correlation Between Circulating Biomarkers of Fungal Bioburden and Clinical Outcome in the Setting of Invasive Aspergillosis
Status: Archived
Updated: 1/1/1970
An Observational Study of Fungal Biomarkers (0000-089)
A Prospective, Non-Intervention, Observational Assessment of the Correlation Between Circulating Biomarkers of Fungal Bioburden and Clinical Outcome in the Setting of Invasive Aspergillosis
Status: Archived
An Observational Study of Fungal Biomarkers (0000-089)
Updated: 1/1/1970
A Prospective, Non-Intervention, Observational Assessment of the Correlation Between Circulating Biomarkers of Fungal Bioburden and Clinical Outcome in the Setting of Invasive Aspergillosis
Status: Archived
Updated: 1/1/1970
An Observational Study of Fungal Biomarkers (0000-089)
A Prospective, Non-Intervention, Observational Assessment of the Correlation Between Circulating Biomarkers of Fungal Bioburden and Clinical Outcome in the Setting of Invasive Aspergillosis
Status: Archived
An Observational Study of Fungal Biomarkers (0000-089)
Updated: 1/1/1970
A Prospective, Non-Intervention, Observational Assessment of the Correlation Between Circulating Biomarkers of Fungal Bioburden and Clinical Outcome in the Setting of Invasive Aspergillosis
Status: Archived
Updated: 1/1/1970
An Observational Study of Fungal Biomarkers (0000-089)
A Prospective, Non-Intervention, Observational Assessment of the Correlation Between Circulating Biomarkers of Fungal Bioburden and Clinical Outcome in the Setting of Invasive Aspergillosis
Status: Archived
An Observational Study of Fungal Biomarkers (0000-089)
Updated: 1/1/1970
A Prospective, Non-Intervention, Observational Assessment of the Correlation Between Circulating Biomarkers of Fungal Bioburden and Clinical Outcome in the Setting of Invasive Aspergillosis
Status: Archived
Updated: 1/1/1970
An Observational Study of Fungal Biomarkers (0000-089)
A Prospective, Non-Intervention, Observational Assessment of the Correlation Between Circulating Biomarkers of Fungal Bioburden and Clinical Outcome in the Setting of Invasive Aspergillosis
Status: Archived
An Observational Study of Fungal Biomarkers (0000-089)
Updated: 1/1/1970
A Prospective, Non-Intervention, Observational Assessment of the Correlation Between Circulating Biomarkers of Fungal Bioburden and Clinical Outcome in the Setting of Invasive Aspergillosis
Status: Archived
Updated: 1/1/1970
An Observational Study of Fungal Biomarkers (0000-089)
A Prospective, Non-Intervention, Observational Assessment of the Correlation Between Circulating Biomarkers of Fungal Bioburden and Clinical Outcome in the Setting of Invasive Aspergillosis
Status: Archived
An Observational Study of Fungal Biomarkers (0000-089)
Updated: 1/1/1970
A Prospective, Non-Intervention, Observational Assessment of the Correlation Between Circulating Biomarkers of Fungal Bioburden and Clinical Outcome in the Setting of Invasive Aspergillosis
Status: Archived
Updated: 1/1/1970
An Observational Study of Fungal Biomarkers (0000-089)
A Prospective, Non-Intervention, Observational Assessment of the Correlation Between Circulating Biomarkers of Fungal Bioburden and Clinical Outcome in the Setting of Invasive Aspergillosis
Status: Archived
An Observational Study of Fungal Biomarkers (0000-089)
Updated: 1/1/1970
A Prospective, Non-Intervention, Observational Assessment of the Correlation Between Circulating Biomarkers of Fungal Bioburden and Clinical Outcome in the Setting of Invasive Aspergillosis
Status: Archived
Updated: 1/1/1970
An Observational Study of Fungal Biomarkers (0000-089)
A Prospective, Non-Intervention, Observational Assessment of the Correlation Between Circulating Biomarkers of Fungal Bioburden and Clinical Outcome in the Setting of Invasive Aspergillosis
Status: Archived
An Observational Study of Fungal Biomarkers (0000-089)
Updated: 1/1/1970
A Prospective, Non-Intervention, Observational Assessment of the Correlation Between Circulating Biomarkers of Fungal Bioburden and Clinical Outcome in the Setting of Invasive Aspergillosis
Status: Archived
Updated: 1/1/1970
An Observational Study of Fungal Biomarkers (0000-089)
A Prospective, Non-Intervention, Observational Assessment of the Correlation Between Circulating Biomarkers of Fungal Bioburden and Clinical Outcome in the Setting of Invasive Aspergillosis
Status: Archived
An Observational Study of Fungal Biomarkers (0000-089)
Updated: 1/1/1970
A Prospective, Non-Intervention, Observational Assessment of the Correlation Between Circulating Biomarkers of Fungal Bioburden and Clinical Outcome in the Setting of Invasive Aspergillosis
Status: Archived
Updated: 1/1/1970
An Observational Study of Fungal Biomarkers (0000-089)
A Prospective, Non-Intervention, Observational Assessment of the Correlation Between Circulating Biomarkers of Fungal Bioburden and Clinical Outcome in the Setting of Invasive Aspergillosis
Status: Archived
An Observational Study of Fungal Biomarkers (0000-089)
Updated: 1/1/1970
A Prospective, Non-Intervention, Observational Assessment of the Correlation Between Circulating Biomarkers of Fungal Bioburden and Clinical Outcome in the Setting of Invasive Aspergillosis
Status: Archived
Updated: 1/1/1970
Fecal Calprotectin in Cystic Fibrosis
Updated: 1/1/1970
Fecal Calprotectin in Cystic Fibrosis
Status: Archived
Updated: 1/1/1970
Prevalence of Sleep Apnea in Patients Presenting for Hip or Knee Replacement Surgery
Prevalence of Sleep Apnea in Patients Presenting for Hip or Knee Replacement Surgery
Status: Archived
Prevalence of Sleep Apnea in Patients Presenting for Hip or Knee Replacement Surgery
Updated: 1/1/1970
Prevalence of Sleep Apnea in Patients Presenting for Hip or Knee Replacement Surgery
Status: Archived
Updated: 1/1/1970
Study of STX-100 in Renal Transplant Patients With Interstitial Fibrosis and Tubular Atrophy (IF/TA)
Randomized Double-Blind, Placebo-Controlled, Single and Multiple Dose, Dose-Escalation Study of STX 100 in Renal Transplant Patients With Biopsy Proven Interstitial Fibrosis and Tubular Atrophy (IF/TA)
Status: Archived
Study of STX-100 in Renal Transplant Patients With Interstitial Fibrosis and Tubular Atrophy (IF/TA)
Updated: 1/1/1970
Randomized Double-Blind, Placebo-Controlled, Single and Multiple Dose, Dose-Escalation Study of STX 100 in Renal Transplant Patients With Biopsy Proven Interstitial Fibrosis and Tubular Atrophy (IF/TA)
Status: Archived
Updated: 1/1/1970
Novel Non-Invasive Monitoring Parameter in a Hospital Setting
A Novel Cardio-Respiratory Parameter in a Hospital Setting
Status: Archived
Novel Non-Invasive Monitoring Parameter in a Hospital Setting
Updated: 1/1/1970
A Novel Cardio-Respiratory Parameter in a Hospital Setting
Status: Archived
Updated: 1/1/1970
Novel Non-Invasive Monitoring Parameter in a Hospital Setting
A Novel Cardio-Respiratory Parameter in a Hospital Setting
Status: Archived
Novel Non-Invasive Monitoring Parameter in a Hospital Setting
Updated: 1/1/1970
A Novel Cardio-Respiratory Parameter in a Hospital Setting
Status: Archived
Updated: 1/1/1970
Safety Study of Respiratory Syncytial Virus F (RSV-F) Vaccine to Treat the Respiratory Syncytial Virus in Healthy Adults 18 to 49 Years of Age
A Phase 1 Randomized, Observer-Blinded,Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of a Recombinant Respiratory Syncytial Virus F Protein Particle Vaccine in Healthy Adults
Status: Archived
Safety Study of Respiratory Syncytial Virus F (RSV-F) Vaccine to Treat the Respiratory Syncytial Virus in Healthy Adults 18 to 49 Years of Age
Updated: 1/1/1970
A Phase 1 Randomized, Observer-Blinded,Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of a Recombinant Respiratory Syncytial Virus F Protein Particle Vaccine in Healthy Adults
Status: Archived
Updated: 1/1/1970
Device-guided Breathing for Shortness of Breath in COPD
Device-guided Slow Breathing in COPD Patients With Clinically Significant Dyspnea: Phase 2
Status: Archived
Device-guided Breathing for Shortness of Breath in COPD
Updated: 1/1/1970
Device-guided Slow Breathing in COPD Patients With Clinically Significant Dyspnea: Phase 2
Status: Archived
Updated: 1/1/1970
Behavioral Incentives to Increase Exercise in Cocaine Dependent Women
Using Behavioral Incentives to Promote Exercise Compliance in Cocaine Dependent Women
Status: Archived
Behavioral Incentives to Increase Exercise in Cocaine Dependent Women
Updated: 1/1/1970
Using Behavioral Incentives to Promote Exercise Compliance in Cocaine Dependent Women
Status: Archived
Updated: 1/1/1970
Electrical Impedance Tomography (EIT) Monitoring in Adults With ALI or ARDS
Electrical Impedance Tomography (EIT) Monitoring: A Pilot Comparison to Standard of Care Assessments in Adults With Acute Lung Injury or Acute Respiratory Distress Syndrome (ARDS)
Status: Archived
Electrical Impedance Tomography (EIT) Monitoring in Adults With ALI or ARDS
Updated: 1/1/1970
Electrical Impedance Tomography (EIT) Monitoring: A Pilot Comparison to Standard of Care Assessments in Adults With Acute Lung Injury or Acute Respiratory Distress Syndrome (ARDS)
Status: Archived
Updated: 1/1/1970
Assessing the Impact of Varenicline on Brain-Behavior Vulnerability
Assessing the Impact of Varenicline on Brain-Behavior Vulnerability in Cocaine Dependence
Status: Archived
Assessing the Impact of Varenicline on Brain-Behavior Vulnerability
Updated: 1/1/1970
Assessing the Impact of Varenicline on Brain-Behavior Vulnerability in Cocaine Dependence
Status: Archived
Updated: 1/1/1970
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
Updated: 1/1/1970
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Updated: 1/1/1970
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
Updated: 1/1/1970
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Updated: 1/1/1970
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
Updated: 1/1/1970
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Updated: 1/1/1970
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
Updated: 1/1/1970
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Updated: 1/1/1970
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
Updated: 1/1/1970
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Updated: 1/1/1970
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
Updated: 1/1/1970
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Updated: 1/1/1970
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
Updated: 1/1/1970
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Updated: 1/1/1970
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
Updated: 1/1/1970
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Updated: 1/1/1970
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
Updated: 1/1/1970
A Large Simple Safety Study of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Archived
Updated: 1/1/1970